Suppr超能文献

心脏移植后需要起搏器治疗的缓慢性心律失常的长期结果和临床预测因素:分析 UNOS/OPTN 心脏移植数据库。

Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant database.

机构信息

Cardiovascular Medicine/Electrophysiology, Cleveland Clinic, Heart and Vascular Institute, Cleveland, Ohio 44195, USA.

出版信息

Heart Rhythm. 2010 Nov;7(11):1567-71. doi: 10.1016/j.hrthm.2010.06.026. Epub 2010 Jun 22.

Abstract

BACKGROUND

Pacemaker-requiring bradyarrhythmias after cardiac transplantation are common, and rarely can lead to sudden cardiac death. Prior outcomes studies have been limited to single-center data.

OBJECTIVE

This study sought to define the long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias in the cardiac transplant population.

METHODS

This study used multivariable analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network (UNOS/OPTN) database of sequential U.S. cardiac transplant recipients from 1997 to 2007 stratified by postoperative bradyarrhythmias requiring a pacemaker. The primary end point was all-cause mortality.

RESULTS

Among 35,987 cardiac transplant recipients (age 46.1 ± 18.3 years, 76% male, 22% bicaval technique) with a follow-up of 6.3 ± 4.7 years, pacemaker-requiring bradyarrhythmias occurred in 3,940 patients (10.9%). Pacemaker recipients demonstrated improved survival (median 8.0 years vs. 5.2 years, P < .001), decreased 5-year mortality (13.8% vs. 17.7%, P < .001), and overall crude mortality (42.9% vs. 45.9%, P < .001). Multivariable propensity-score-adjusted analysis demonstrated improved survival among pacemaker recipients (adjusted hazard ratio 0.84, 95% confidence interval [CI] 0.80 to 0.88, P < .001) after adjustment for donor/recipient age, UNOS listing status, donor heart ischemic time, surgical technique, graft rejection, and other common comorbidities. The bicaval surgical technique was strongly protective against a postoperative pacemaker requirement (odds ratio [OR] 0.33, 95% CI 0.29 to 0.36, P < .001) in multivariable analysis. Among the other variables studied, only increasing donor age (OR 1.04, 95% CI 1.00 to 1.09, P < .001) and recipient age (OR 1.09, 95% CI 1.0 to 1.12, P < .001) were associated with a permanent pacemaker requirement.

CONCLUSION

Cardiac transplant recipients with pacemaker-requiring bradyarrhythmias have an excellent long-term prognosis. Increased mortality in the nonpacemaker group merits further investigation. Biatrial surgical technique and increasing donor/recipient age are associated with postoperative pacemaker requirement.

摘要

背景

心脏移植后需要起搏器的心动过缓很常见,很少会导致心脏性猝死。先前的研究结果仅限于单中心数据。

目的

本研究旨在确定心脏移植人群中需要起搏器的心动过缓的长期结果和临床预测因素。

方法

本研究使用了美国 1997 年至 2007 年接受心脏移植的连续患者的美国器官共享/器官获取和移植网络(UNOS/OPTN)数据库的多变量分析,根据术后需要起搏器的缓慢性心律失常进行分层。主要终点是全因死亡率。

结果

在 35987 例接受心脏移植(年龄 46.1±18.3 岁,76%为男性,22%为双房技术)并随访 6.3±4.7 年的患者中,有 3940 例(10.9%)需要起搏器治疗的缓慢性心律失常。起搏器患者的生存情况得到改善(中位生存期 8.0 年 vs. 5.2 年,P<0.001),5 年死亡率降低(13.8% vs. 17.7%,P<0.001),总体粗死亡率降低(42.9% vs. 45.9%,P<0.001)。多变量倾向评分调整分析表明,在调整供体/受体年龄、UNOS 登记状态、供体心脏缺血时间、手术技术、移植物排斥和其他常见合并症后,起搏器患者的生存情况得到改善(调整后的风险比 0.84,95%置信区间[CI]0.80 至 0.88,P<0.001)。在多变量分析中,双房手术技术强烈保护术后不需要起搏器(比值比[OR]0.33,95%CI0.29 至 0.36,P<0.001)。在所研究的其他变量中,只有供体年龄增加(OR 1.04,95%CI1.00 至 1.09,P<0.001)和受体年龄增加(OR 1.09,95%CI1.00 至 1.12,P<0.001)与永久性起搏器需求相关。

结论

需要起搏器的心动过缓的心脏移植患者有极好的长期预后。非起搏器组死亡率增加需要进一步调查。双心房手术技术和供体/受体年龄增加与术后起搏器需求相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验